Takeda Pharmaceutical Company Limited (LON:0A87)
London · Delayed Price · Currency is GBP · Price in USD 15.38
+0.50 (3.36%)
At close: Jul 2, 2025
LON:0A87 Revenue
In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T JPY with 7.45% growth. Takeda Pharmaceutical Company had revenue of 1.05T in the quarter ending March 31, 2025, with 0.24% growth.
Revenue
4,581.55B JPY
Revenue Growth
+7.45%
P/S Ratio
1.45
Revenue / Employee
96.55M JPY
Employees
47,455
Market Cap
34.35B GBP
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4,581.55B | 317.79B | 7.45% |
| Mar 31, 2024 | 4,263.76B | 236.28B | 5.87% |
| Mar 31, 2023 | 4,027.48B | 458.47B | 12.85% |
| Mar 31, 2022 | 3,569.01B | 371.19B | 11.61% |
| Mar 31, 2021 | 3,197.81B | -93.38B | -2.84% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HSBC Holdings | 44.89B |
| AstraZeneca | 42.56B |
| Shell | 217.54B |
| Unilever | 50.25B |
| Rolls-Royce Holdings | 18.91B |
| British American Tobacco p.l.c. | 25.87B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |